Italia markets closed

BMY Dec 2024 46.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
4,0000-0,6500 (-13,98%)
Alla chiusura: 03:13PM EDT
Schermo intero
Chiusura precedente4,6500
Aperto4,1000
Denaro3,8500
Lettera4,0000
Prezzo d'esercizio46,00
Scadenza2024-12-20
Min-Max giorno4,0000 - 4,1000
Contratto - Min-MaxN/D
Volume13
Open Interest324
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri